Skip to main content
. 2009 Aug 25;101(7):1183–1193. doi: 10.1038/sj.bjc.6605249

Figure 5.

Figure 5

In vivo distribution of 125I-VEGF121b in tumour-bearing mice. Tumour-bearing mice received an intravenous injection of 125I-VEGF121b and 3D imaged using NanoSPECT/CT. (AD) Time course for biodistribution of 125I-VEGF121b after tail vein injection using transverse sections. (E) Coronal. (F) Para-sagittal through the centre of the tumour. The tumour is circled and arrows indicate different organs. (G) Quantification uptake into different organs and tissues over time. Data expressed as % in tissue relative to the total injected dose, per gram of tissue.

HHS Vulnerability Disclosure